JPWO2023108260A5 - - Google Patents
Info
- Publication number
- JPWO2023108260A5 JPWO2023108260A5 JP2024535372A JP2024535372A JPWO2023108260A5 JP WO2023108260 A5 JPWO2023108260 A5 JP WO2023108260A5 JP 2024535372 A JP2024535372 A JP 2024535372A JP 2024535372 A JP2024535372 A JP 2024535372A JP WO2023108260 A5 JPWO2023108260 A5 JP WO2023108260A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- pharmaceutical composition
- composition according
- zwitterion
- replaced
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163289501P | 2021-12-14 | 2021-12-14 | |
| US63/289,501 | 2021-12-14 | ||
| PCT/CA2022/051797 WO2023108260A1 (en) | 2021-12-14 | 2022-12-08 | Tryptamine prodrugs |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024546138A JP2024546138A (ja) | 2024-12-17 |
| JPWO2023108260A5 true JPWO2023108260A5 (https=) | 2025-12-24 |
| JP2024546138A5 JP2024546138A5 (https=) | 2025-12-24 |
Family
ID=86775179
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024535372A Pending JP2024546138A (ja) | 2021-12-14 | 2022-12-08 | トリプタミンプロドラッグ |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20250051278A1 (https=) |
| EP (1) | EP4448489A4 (https=) |
| JP (1) | JP2024546138A (https=) |
| CN (1) | CN118679146A (https=) |
| CA (1) | CA3240633A1 (https=) |
| WO (1) | WO2023108260A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023168023A1 (en) | 2022-03-04 | 2023-09-07 | Reset Pharmaceuticals, Inc. | Co-crystals or salts comprising psilocin |
| WO2025250900A1 (en) * | 2024-05-30 | 2025-12-04 | Caamtech, Inc. | 4-hydroxy-n,n-diisopropyltryptaminium hydroglutarate |
| WO2026024591A1 (en) * | 2024-07-22 | 2026-01-29 | Reunion Neuroscience, Inc. | Tryptamine prodrug solid forms |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PH12022551981A1 (en) * | 2020-02-04 | 2023-10-16 | Mindset Pharma Inc | Psilocin derivatives as serotonergic psychedelic agents for the treatment of cns disorders |
| CN115867533B (zh) * | 2020-06-30 | 2024-07-23 | 加拿大瑞安神经科学公司 | 色胺前药 |
| EP4263504A4 (en) * | 2020-12-18 | 2025-05-14 | COMPASS Pathfinder Limited | Modified indole alkaloids for therapeutic uses |
-
2022
- 2022-12-08 JP JP2024535372A patent/JP2024546138A/ja active Pending
- 2022-12-08 EP EP22905564.5A patent/EP4448489A4/en active Pending
- 2022-12-08 US US18/719,620 patent/US20250051278A1/en active Pending
- 2022-12-08 CA CA3240633A patent/CA3240633A1/en active Pending
- 2022-12-08 WO PCT/CA2022/051797 patent/WO2023108260A1/en not_active Ceased
- 2022-12-08 CN CN202280082458.9A patent/CN118679146A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPWO2022000091A5 (https=) | ||
| CN103249697B (zh) | 适用作多巴胺能稳定剂的普利多匹定(pridopidine)氘化类似物 | |
| JP5253696B2 (ja) | 抗腫瘍作用を有するインドリル−３−グリオキシル酸誘導体 | |
| JP5064024B2 (ja) | イマチニブの製造方法、及び該方法により製造されたイマチニブ | |
| RU2213089C2 (ru) | Моноциклические бензамиды производных 3- или 4-замещенного 4-(аминометил)пиперидина, способы их получения, фармацевтическая композиция, способ ее приготовления, производное карбоновой кислоты | |
| KR100878416B1 (ko) | 피페라진 화합물 | |
| JPS584752A (ja) | カルボキシアミド誘導体及びその製造法 | |
| JPH0729922B2 (ja) | ２‐アルコキシ‐ｎ‐（１‐アザビシクロ［２，２，２オクト‐３‐イル）ベンズアミド類およびチオベンズアミド類 | |
| JP6087367B2 (ja) | 三環式化合物、それらを含む組成物およびそれらの使用 | |
| JPH01226818A (ja) | アリールアミドアザビシクロアルカン類およびアリールチオアミドアザビシクロアルカン類からなる記憶力増進剤または記憶障害治療剤 | |
| WO1988002365A1 (fr) | Derives d'amines cycliques | |
| IE922523A1 (en) | New 5-isoquinolinesulfonamides process for preparing them and pharmaceutical compositions containing them | |
| JPH03145488A (ja) | 新規ニコチン類似体 | |
| JP2009531465A (ja) | 中枢神経系障害の治療のための（２ｓ）−（４ｅ）−ｎ−メチル−５−［３−（５−イソプロポキシピリジン）イル］−４−ペンテン−２−アミンの多形形態 | |
| WO1999052525A1 (es) | Tienilazolilalcoxietanaminas, su preparacion y su aplicacion como medicamentos | |
| JOP20240217A1 (ar) | مشتقات الكوينولين كمُعدِّلات للعضو x2 لمستقبل بروتين g مرتبط بـ mas ومنتجات ذات صلة | |
| AU772745B2 (en) | Substituted N-Benzyl-indol-3-YL glyoxylic acid derivatives having an anti-tumoral effect | |
| JP2019537624A5 (https=) | ||
| JP2006511506A5 (https=) | ||
| JPWO2023108260A5 (https=) | ||
| JP2005532269A5 (https=) | ||
| JPS6240357B2 (https=) | ||
| JPH0674264B2 (ja) | １―（ピリジニルアミノ）―２―ピロリジノンおよびその製造法 | |
| JP2005533038A5 (https=) | ||
| IE66601B1 (en) | 2,3-Dihydro-1-(pyridinylamino)-indoles a process for their preparation and their use as medicaments |